How does Aimovig work to prevent migraines?
Aimovig is a fully human monoclonal antibody and is the first in the class of calcitonin gene-related peptide (CGRP) receptor antagonists for migraine prevention.
Aimovig is given once-a-month by subcutaneous (under the skin) self-injections with an auto-injector pen or a single-dose prefilled syringe.
Related medical questions
- What are the new drugs for the treatment of migraines?
- Ajovy vs Aimovig: What's the difference between them?
- Why does Aimovig cause constipation?
- How long does Aimovig last in your system?
- What is the mechanism of action of Aimovig?
- Can you drink alcohol with Aimovig?
- Can Aimovig cause hair loss (alopecia)?
- How do you use the Aimovig autoinjector?
- Which medication should I use for migraine headaches?
- Emgality vs Aimovig - how do they compare?
- How long does it take for Aimovig to start working?